Raia Drogasil S.A.
RADLY
$3.56
$0.2597.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.69% | -0.31% | 6.03% | 12.31% | 18.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.69% | -0.31% | 6.03% | 12.31% | 18.33% |
| Cost of Revenue | -1.06% | 0.28% | 6.55% | 12.68% | 18.63% |
| Gross Profit | -3.18% | -1.68% | 4.84% | 11.44% | 17.61% |
| SG&A Expenses | -2.98% | -1.24% | 3.92% | 11.57% | 18.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 119.50% | 123.22% | 148.46% | -10.65% | -263.29% |
| Total Operating Expenses | -1.15% | 0.35% | 6.49% | 12.40% | 18.43% |
| Operating Income | -9.83% | -9.96% | -0.78% | 10.92% | 16.74% |
| Income Before Tax | -10.03% | -7.98% | 7.69% | 14.39% | 11.68% |
| Income Tax Expenses | -65.18% | -31.39% | 55.51% | 136.06% | 66.33% |
| Earnings from Continuing Operations | 1.51% | -3.42% | 1.95% | 1.08% | 4.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 57.81% | 79.96% | 65.82% | -65.26% | -72.45% |
| Net Income | 3.20% | -1.09% | 4.03% | 0.04% | 3.34% |
| EBIT | -9.83% | -9.96% | -0.78% | 10.92% | 16.74% |
| EBITDA | -8.22% | -8.76% | -0.58% | 9.36% | 15.17% |
| EPS Basic | 20.63% | -11.78% | -6.00% | -11.02% | -8.89% |
| Normalized Basic EPS | -1.41% | -22.30% | -9.66% | 1.73% | 3.39% |
| EPS Diluted | 20.50% | -11.81% | -6.09% | -11.07% | -8.68% |
| Normalized Diluted EPS | -1.64% | -22.35% | -9.80% | 1.62% | 3.52% |
| Average Basic Shares Outstanding | -16.78% | 16.13% | 15.06% | 16.06% | 16.21% |
| Average Diluted Shares Outstanding | -16.64% | 16.07% | 14.87% | 15.83% | 15.71% |
| Dividend Per Share | -18.46% | -36.31% | -63.79% | 213.81% | 1.66% |
| Payout Ratio | -0.02% | -0.08% | -0.12% | 0.05% | 0.02% |